(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DOPLIFY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

DOPLIFY

ST13

US500000099169872

Class

1

Filing

99169872

Registration

8183775

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

20

Latest update

03/25/2026

Trademark type

Word

Nice classes

1

Filing date

05/05/2025

Registration date

03/24/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/24/2026

Last transaction

03/25/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

08/29/2016

First use in commerce

01/27/2017

Drawing code

4

Owner type

03

Owner location

Waltham, MA, US

Examiner

OGUNFEMI, RASHEEDAT

Law office

O40

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Revvity Holdings, Inc.

Representatives

Kevin A. Oliver Revvity, Inc.

Technical classification

Nice Classes

Class 1

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Reagents and kits consisting primarily of reagents for nucleic acid amplification for scientificforensicresearch use; reagents and kits consisting primarily of reagents for polymerase chain reaction for scientificforensicresearch use; polymerase chain reaction (PCR) reagents and kits consisting primarily of polymerase chain reaction (PCR) reagents for scientificforensicresearch use; polymerase chain reaction (PCR) kits comprising nucleotide solutionsoligonucleotidesbuffersreaction reagents for scientificforensicresearch use; reagents and kits consisting primarily of reagents for whole genome amplification for scientificforensicresearch use; reagents and kits consisting primarily of reagents for whole genome application from single cells or limited DNA templates for scientificforensicresearch use; reagents and kits consisting primarily of reagents for chromosomalgenomicmitochondrialgenetic and/or sequencing analyses using whole genome amplification for scientificforensicresearch use; chemical preparations for scientific purposesother than for medical or veterinary use; chemical preparations for analyses in laboratoriesother than for medical or veterinary purposes

Publications

History of USPTO decisions and trademark events.

20 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

03/24/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

03/24/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/03/2026

PUBO

PUBLISHED FOR OPPOSITION

02/03/2026

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/28/2026

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/09/2026

XAEC

EXAMINER'S AMENDMENT ENTERED

01/09/2026

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

01/09/2026

GNEA

EXAMINERS AMENDMENT E-MAILED

01/09/2026

CNEA

EXAMINERS AMENDMENT -WRITTEN

01/09/2026

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/07/2026

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/07/2026

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/07/2026

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/08/2025

GNRT

NON-FINAL ACTION E-MAILED

10/08/2025

CNRT

NON-FINAL ACTION WRITTEN

10/08/2025

DOCK

ASSIGNED TO EXAMINER

09/22/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/21/2025

MAFR

APPLICATION FILING RECEIPT MAILED

05/05/2025

NWAP

NEW APPLICATION ENTERED

05/05/2025

Continuous trademark protection

Get notified about every new filing that threatens DOPLIFY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.